The investment was led by MMC Ventures and will fund team expansion and product development.
"The digital asset landscape is evolving rapidly, with top-tier market makers redefining execution speed and efficiency. As a result, demand for advanced trading tools is increasing . ABEX is committed to levelling the playing field for buy-side clients by providing cutting-edge, research-driven execution algorithms. This funding enables us to continue enhancing our technology, scaling our team, and delivering best-in-class solutions for institutional traders."
Symvan Capital backs Bristol artificial intelligence startup Tikos to address the black box problem.
"We’re excited to support Mike and Don in making AI systems trustworthy and compliant, addressing one of the most urgent challenges in AI. With over a decade of proprietary research, their ability to retrofit explainability and auditability into existing models is game-changing for regulated industries and high-stakes AI applications."
The agritech startup closed a round backed by biotope, Planetary Impact Ventures, and PINC to accelerate its digital tool development.
"Soil is the foundation of our food system, but modern agriculture has strained its health. The soil microbiome holds the key to restoring fertility, resilience, and reducing reliance on synthetic inputs. By unlocking its potential, we can help farmers produce food sustainably while regenerating the land for future generations."
The financing from Sofinnova Partners and Old College Capital will support the launch of precision fibrosis therapeutics.
"Launching Forth Tx through Sofinnova’s biotech accelerator has allowed us to translate years of our multiomics-driven research into precision therapies that we hope will transform patients’ lives. Fibrosis is an area of huge unmet medical need, and I’m delighted to be working with Alex and the Sofinnova team, as well as OCC, to deliver potent, new treatments for patients with fibrosis."
— Neil Henderson, Chair of Tissue Repair and Regeneration at the University of Edinburgh
Manchester United defender Diogo Dalot has backed the health supplement provider with over £841k.
"When it comes to high-level performance, my biggest focus has always been finding that extra 1% — the key to setting myself apart from the rest. Since discovering Bioniq in 2022, it’s been a game-changer for me. I’ve seen the results for myself. Achieving such progress is only possible with a product that’s truly personalized and tailored specifically to my needs. Now, I’m thrilled to take the next step as an investor. I believe in Bioniq’s mission and see the tremendous potential of this business, especially with the growing global demand for personalized nutrition."
